The outperformance of REITs observed so far in 2026 is, in my opinion, just the tip of the iceberg. Read the full analysis on ...
Inside a panel on provenance standards, AI labelling, and why “trust” now needs tech, policy, and literacy to scale.
Harmony Biosciences (Nasdaq: HRMY) today announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental new drug application (sNDA) for WAKIX® (pitolisant) tablets for the ...